- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Hualan Biological Bacterin Co. Ltd.
Total 463 results
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Solid TumorsChina
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedNon-small Cell Lung CancerChina
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced or Metastatic NSCLCChina
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.SuspendedMyelodysplastic SyndromesChina
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Unknown
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedRelapsed/Refractory Classical Hodgkin's LymphomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.Terminated
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingHealthy Participants | Atopic Dermatitis PatientsChina
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingLocally Advanced Unresectable or Metastatic Solid TumorsAustralia
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruitingMultiple MyelomaAustralia
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingNeovascular Age-related Macular DegenerationChina
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Zhejiang Doer Biologics Co., Ltd.RecruitingMalignant Neoplasm of Digestive SystemChina
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingLocally Advanced Unresectable or Metastatic Solid TumorsAustralia
-
Zhejiang Doer Biologics Co., Ltd.RecruitingHealthy, Obesity, MetabolicallyNew Zealand
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingUlcerative Colitis (UC)China
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruitingDiffuse Large B-Cell Lymphoma
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedIndolent Non-hodgkin LymphomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Starmab biologics(Shanghai)Co,.ltdActive, not recruitingStaphylococcus Aureus Bloodstream InfectionChina
-
Starmab biologics(Shanghai)Co,.ltdActive, not recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Terminated
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Solid TumorChina
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Suspended
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Malignant Tumors LymphomasUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedHomozygous Familial HypercholesterolemiaChina
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedCLDN18.2 Positive Solid TumorsChina
-
Innovent Biologics (Suzhou) Co. Ltd.TerminatedAdvanced Cutaneous Squamous Cell CarcinomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.TerminatedA Study of Sintilimab Plus Ramucirumab as First-line Treatment for G/EGJ Adenocarcinoma (ORIENT-106)Gastric AdenocarcinomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Solid TumorsChina
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Solid TumorsChina